Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique
- 1 March 1985
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 63 (6) , 252-256
- https://doi.org/10.1007/bf01731470
Abstract
Control of anticoagulation during cardiopulmonary bypass (CPB) with the automated activated whole blood clotting time (ACT) and reversal of heparin after CPB using a computerized ACT dose-response curve method resulted in significant reductions of blood transfusion requirements, surgical time, and protamine doses in 150 patients undergoing coronary artery bypass grafting procedures (ACT group) as compared to 200 patients for whom a standard fixed dose protocol for heparin and protamine was used (control patients). Mean transfusion requirements were 1,938±60 SEM ml whole blood and 853±48.3 SEM ml red blood cells for control patients and 1,397±59 SEM ml whole blood (PPPPP<0.001).This publication has 20 references indexed in Scilit:
- Individuelle Heparin- und Protamindosierung in der HerzchirurgieJournal of Molecular Medicine, 1983
- Monitoring Heparin Anticoagulation and Its NeutralizationThe Annals of Thoracic Surgery, 1981
- Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: Magnitude and predictability of interindividual differences*Clinical Pharmacology & Therapeutics, 1980
- Heparin Anticoagulation during Cardiopulmonary Bypass in an Antithrombin-III Deficient Patient: Implications Relative to the Etiology of Heparin ReboundAmerican Journal of Clinical Pathology, 1980
- Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1980
- Use of Activated Coagulation Time to Monitor Heparin during Cardiac SurgeryThe Annals of Thoracic Surgery, 1979
- Anesthesia for Coronary Artery SurgeryPublished by Springer Nature ,1979
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- Control of Heparinization by Activated Clotting Time During Bypass with Improved Postoperative HemostasisThe Annals of Thoracic Surgery, 1977
- Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1977